A Ogunbajo1, C E Hansen2, A L North1, E Okoloko1, L M Niccolai1,3,4. 1. Yale School of Public Health, New Haven, CT, USA. 2. Yale School of Medicine, New Haven, CT, USA. 3. Yale Center for Interdisciplinary Research on AIDS, New Haven, CT, USA. 4. Yale Cancer Center, New Haven, CT, USA.
Abstract
BACKGROUND: Human papillomavirus (HPV) vaccination is recommended for routine administration at ages 11-12 years. However, uptake is lower than for other vaccines that are also routinely recommended for adolescents (MCV4 and Tdap). Understanding parental perceptions of HPV vaccine compared with other vaccines may help to inform strategies to increase uptake. METHODS: Parents and caregivers (n = 45) of adolescents ages 10-18 years from a low-income, ethnic minority population participated in a qualitative study. Interviews were transcribed verbatim and coded for emergent themes. RESULTS: Many participants perceived the HPV vaccine to be similar to other routine vaccines. Noted similarities included the vaccines' ability to prevent disease, similar methods of administration and belief in health care providers' recommendation. Some parents noted the greater benefit of HPV vaccine in preventing cancer, which was viewed as a serious disease. Parents also noted the different mode of transmission (sexual) for HPV, which evoked mixed opinions. CONCLUSION: Overall, most participants viewed the HPV vaccine in a positive light and similar to other adolescent vaccines with the added benefit of cancer prevention. Strategies that treat all three vaccines equally such as presenting them similarly as a 'bundle' to parents or considering policy initiatives such as school entry requirements might help increase raise coverage for HPV vaccine.
BACKGROUND:Human papillomavirus (HPV) vaccination is recommended for routine administration at ages 11-12 years. However, uptake is lower than for other vaccines that are also routinely recommended for adolescents (MCV4 and Tdap). Understanding parental perceptions of HPV vaccine compared with other vaccines may help to inform strategies to increase uptake. METHODS: Parents and caregivers (n = 45) of adolescents ages 10-18 years from a low-income, ethnic minority population participated in a qualitative study. Interviews were transcribed verbatim and coded for emergent themes. RESULTS: Many participants perceived the HPV vaccine to be similar to other routine vaccines. Noted similarities included the vaccines' ability to prevent disease, similar methods of administration and belief in health care providers' recommendation. Some parents noted the greater benefit of HPV vaccine in preventing cancer, which was viewed as a serious disease. Parents also noted the different mode of transmission (sexual) for HPV, which evoked mixed opinions. CONCLUSION: Overall, most participants viewed the HPV vaccine in a positive light and similar to other adolescent vaccines with the added benefit of cancer prevention. Strategies that treat all three vaccines equally such as presenting them similarly as a 'bundle' to parents or considering policy initiatives such as school entry requirements might help increase raise coverage for HPV vaccine.
Authors: Meg Watson; Mona Saraiya; Vicki Benard; Steven S Coughlin; Lisa Flowers; Vilma Cokkinides; Molly Schwenn; Youjie Huang; Anna Giuliano Journal: Cancer Date: 2008-11-15 Impact factor: 6.860
Authors: Emiko Petrosky; Joseph A Bocchini; Susan Hariri; Harrell Chesson; C Robinette Curtis; Mona Saraiya; Elizabeth R Unger; Lauri E Markowitz Journal: MMWR Morb Mortal Wkly Rep Date: 2015-03-27 Impact factor: 17.586
Authors: Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2015-07-31 Impact factor: 17.586
Authors: Christy A Widman; Elisa M Rodriguez; Frances Saad-Harfouche; Annamaria Masucci Twarozek; Deborah O Erwin; Martin C Mahoney Journal: J Cancer Educ Date: 2018-04 Impact factor: 2.037
Authors: Adedotun Ogunbajo; Trace Kershaw; Sameer Kushwaha; Francis Boakye; Nii-Dromo Wallace-Atiapah; LaRon E Nelson Journal: AIDS Behav Date: 2018-03
Authors: Annika M Hofstetter; Jeffrey D Robinson; Katherine Lepere; Morgan Cunningham; Nicole Etsekson; Douglas J Opel Journal: Vaccine Date: 2017-04-06 Impact factor: 3.641
Authors: Elisabeth Rb Becker; Ross Shegog; Lara S Savas; Erica L Frost; C Mary Healy; Stanley W Spinner; Sally W Vernon Journal: JMIR Form Res Date: 2021-11-19
Authors: Vivian Colón-López; Diana T Medina-Laabes; Roxana Soto Abreu; Olga L Díaz Miranda; Ana P Ortiz; María E Fernández; Pamela C Hull Journal: BMC Public Health Date: 2021-10-25 Impact factor: 3.295